FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis

Miguel A Zaballos1, Pilar Santisteban

  • 1Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, 28029 Madrid, Spain.

Insights

Thyroid-stimulating hormone (TSH) and insulin/IGF-I signaling impact thyroid cell proliferation. Forkhead box O (FoxO)1 acts as a key regulator, with its reduced expression linked to thyroid tumor growth.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyroid-stimulating hormone (TSH) and insulin/IGF-I synergistically promote thyroid cell proliferation via cAMP and phosphatidylinositol 3-kinase (PI3K) pathways.
  • The PI3K pathway's activation in thyroid malignancies highlights its significance.
  • Forkhead box O (FoxO)-1, a PI3K target, is crucial for cellular processes including proliferation and apoptosis.

Purpose of the Study:

  • To investigate the role of FoxO1 as an integrator of TSH and IGF-I signaling in thyroid cell proliferation.
  • To determine the expression patterns of FoxO1 in normal and cancerous thyroid tissues.
  • To elucidate the regulatory mechanisms of FoxO1 by TSH and IGF-I and its impact on thyroid cell growth.

Main Methods:

  • Quantitative analysis of FoxO1 mRNA and protein levels in differentiated thyroid cells and tumor cells.
  • Assessment of FoxO1 nuclear exclusion via Akt-dependent signaling pathways.
  • Manipulation of FoxO1 expression in thyroid cells to evaluate its effect on proliferation rates.

Main Results:

  • FoxO1 expression is significantly reduced in thyroid tumor cells compared to differentiated thyroid cells.
  • TSH/cAMP decreases FoxO1 levels through proteasome degradation, while TSH and IGF-I promote nuclear exclusion via Akt.
  • FoxO1 re-expression inhibits tumor cell proliferation, and its interference increases differentiated cell proliferation.

Conclusions:

  • FoxO1 plays a critical role in mediating the proliferative effects of TSH and IGF-I on thyroid cells.
  • Reduced FoxO1 expression is associated with the uncontrolled proliferation observed in thyroid tumors.
  • FoxO1 represents a potential therapeutic target for thyroid cancer treatment.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...